Cymbalta Users Beware

July 21, 2015 Hastings and Hastings
In August of 2004, the FDA approved of the drug Cymbalta to treat depression. Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) which functions by managing certain brain chemical associated with mental stability. The drug was later found to treat other conditions such as: anxiety, muscle pain, urinary incontinence, stress, and even diabetic neuropathy. The...
Read More